GRI Bio Inc (NASDAQ: GRI) kicked off on Tuesday, up 3.97% from the previous trading day, before settling in for the closing price of $1.51. Over the past 52 weeks, GRI has traded in a range of $1.10-$130.39.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -20.00% over the last five years. While this was happening, its average annual earnings per share was recorded 98.02%. With a float of $0.73 million, this company’s outstanding shares have now reached $0.73 million.
The firm has a total of 4 workers. Let’s measure their productivity. In terms of profitability, gross margin is 46.74%, operating margin of -167.67%, and the pretax margin is -81.41%.
GRI Bio Inc (GRI) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of GRI Bio Inc is 0.05%, while institutional ownership is 1.81%.
GRI Bio Inc (GRI) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.91 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 98.02% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 82.65% during the next five years compared to 70.23% growth over the previous five years of trading.
GRI Bio Inc (NASDAQ: GRI) Trading Performance Indicators
Take a look at GRI Bio Inc’s (GRI) current performance indicators. Last quarter, stock had a quick ratio of 3.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -203.36, a number that is poised to hit -3.46 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of GRI Bio Inc (GRI)
Analysing the last 5-days average volume posted by the [GRI Bio Inc, GRI], we can find that recorded value of 0.29 million was better than the volume posted last year of 0.27 million. As of the previous 9 days, the stock’s Stochastic %D was 26.33%. Additionally, its Average True Range was 1.00.
During the past 100 days, GRI Bio Inc’s (GRI) raw stochastic average was set at 2.97%, which indicates a significant decrease from 4.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 253.44% in the past 14 days, which was higher than the 147.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.0074, while its 200-day Moving Average is $11.4569. Now, the first resistance to watch is $1.8780. This is followed by the second major resistance level at $2.1860. The third major resistance level sits at $2.3920. If the price goes on to break the first support level at $1.3640, it is likely to go to the next support level at $1.1580. Should the price break the second support level, the third support level stands at $0.8500.
GRI Bio Inc (NASDAQ: GRI) Key Stats
The company with the Market Capitalisation of 1.14 million has total of 525K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -8,210 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -1,950 K.
